HMGCR and atherosclerosis: HMG-CoA reductase inhibitors (statins) were shown to regulate the expression of chemokines and cytokines such as MCP-1 and IL-6 hence controlling the migration of leukocytes to sub-endothelial sites of inflammation, thereby favorably affecting atherosclerosis [60].